Studies on dengue 2 virus infection in cyclophosphamide-treated rhesus monkeys

• Published in: Medical microbiology and immunology 1980-02, Vol.168 (1), p.35-47
• Main Authors: Marchette, N J, O'Rourke, T, Halstead, S B
• Format: Article
• Language: English
• Subjects: Animals; Antibodies, Viral - biosynthesis; Cyclophosphamide - administration & dosage; Cyclophosphamide - pharmacology; Dengue - immunology; Dengue - microbiology; Dengue Virus - growth & development; Disease Models, Animal; Haplorhini; Immunosuppression; Macaca mulatta; Neutrophils - microbiology; Viremia - diagnosis; Virus Replication - drug effects
• ISSN: 0300-8584; 1432-1831
• DOI: 10.1007/BF02121650

Dengue 2 virus (D2V) replication has been demonstrated in cultured primate mononuclear phagocytes, mitogen treated lymphocytes and lymphoblastoid cells. To determine which of these cell types might play an important role in sustaining infection in vivo, nine rhesus monkeys were immunosuppressed with cyclophosphamide and then infected with D2V. Maintenance dose which held total white blood cell counts to less than 3000/mm3 ablated both primary and secondary antibody responses. Six successfully immunosuppressed animals circulated virus and infected monocytes in blood for prolonged periods. Virus was recovered from lymphatic organs and visualized in tissue mononuclear leukocytes in two subjects dying during the experimental period. The results argue against the hypothesis that lymphoblasts play an important role in dengue virus infection but are consistent with the possibility that mononuclear phagocytes are the site of viral replication in vivo.